Plexxikon

Plexxikon

Engages in the discovery and development of small molecule pharmaceuticals to treat human disease.

Launch date
Employees
Market cap
-
Enterprise valuation
€27—41m (Dealroom.co estimates Mar 2005.)
Berkeley California (HQ)
Authorizing premium user...